(Dmytro “Henry” Aleksandrov, Headline USA) A group of House Republicans introduced a bill this week to fight for unborn babies by placing restrictions on chemical abortion pills that would limit their use to in-person distribution only.
If the bill is enacted, it would nullify recent rule changes from President Joe Biden’s Food and Drug Administration that allows women to order abortion drugs — mifepristone and misoprostol — via telemedicine and delivered by mail and permits pharmacies to fill prescriptions for abortion pills, according to the Daily Signal.
“The FDA’s policy change for mifepristone is the latest example of President Biden’s crusade toward abortion on demand at any cost, even at the expense of women’s health,” said Rep. Diana Harshbarger, R-Tenn., adding that “… every woman in America deserves to know the heightened risks involved with chemical abortions before they make a life-altering decision.”
The pro-life bill is also designed in a way to prevent the FDA from creating a similar rule later in the future.
“My bill restores common sense and proper safety prescriber requirements for the dispensing of these dangerous abortion drugs.”
The first pill, mifepristone, that a woman takes kills an unborn baby by cutting off progesterone, a hormone the child needs to survive. The pill that a woman takes after that is misoprostol, which causes contractions to expel the baby from the woman’s body. The baby-killing drugs are approved to be taken up to 10 weeks into pregnancy.
Charlotte Lozier Institute, the pro-life research organization, reported that abortion pills have a four-times higher rate of complication than surgical abortion. The Institute stated that “as many as one out of five women will suffer a complication” after taking chemical abortion pills.
“By removing the requirement that women seeking access to the abortion pill must receive the prescription from a medical provider in person, the Biden administration has placed the health and well-being of women in jeopardy,” Rep. Doug Lamborn, R-Colo., one of the co-sponsors of the bill, said.
He also said that FDA’s rule change not only “put women with possible health conditions and concerns at risk for further health complications, but it completely negates the opportunity for women to learn about the options they have, other than terminating their pregnancy.”